<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612234</url>
  </required_header>
  <id_info>
    <org_study_id>R01DK082803</org_study_id>
    <nct_id>NCT01612234</nct_id>
  </id_info>
  <brief_title>Saturated Fat Versus Monounsaturated Fat and Insulin Action</brief_title>
  <official_title>Palmitate Metabolism and Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High intakes of saturated fat are associated with diabetes. Our work has shown that the two
      most common fatty acids in the North American diet, palmitic acid (saturated fat) and oleic
      acid (monounsaturated fat) are metabolized differently and have opposite effects on fat
      burning. The proposed study will examine biochemical and molecular mechanisms for how a high
      saturated fat diet versus a low saturated fat/high monounsaturated fat diet alters the action
      of the hormone, insulin, in skeletal muscle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Palmitic acid (PA), impairs insulin sensitivity in skeletal muscle, and replacing PA in the
      diet with oleic acid (OA), a monounsaturated fatty acid (FA), may be beneficial. The first
      objective of this project is to understand the effects on lipid metabolism and skeletal
      muscle lipid composition, insulin signaling, and inflammatory signaling of two common
      variations in FA composition of the diet: (1) The typical intake of North America where PA
      and OA are present in equal proportions (HI PA diet). (2) The Mediterranean FA composition in
      which PA is much lower and OA much higher (HI OA diet). PA may induce insulin resistance in
      skeletal muscle cells via its accumulation in lipids within muscle cells and via activation
      of inflammatory signaling. The second objective of this project is to assess the hypothesis
      that a high intake of PA will down-regulate its own one-carbon (initial) oxidation, leading
      to increased inflammatory signaling and decreased insulin signaling. However, there is
      literature evidence that FA may induce defects in insulin signaling, if FA are not completely
      oxidized; therefore, the third objective is to assess the hypotheses that a high PA diet may
      decrease complete oxidation of FA and possibly accelerate initial FA oxidation. A
      double-masked, cross-over trial of the effects of a high PA diet versus a high OA/low PA diet
      in 16 overweight or obese subjects and 16 lean subjects (aged 18 - 40 yr) will be conducted
      to investigate the following Specific Aims:

        1. To test the hypothesis that increased intake of PA will cause a decreased rate of
           [1-13C]-PA oxidation and will be associated with: (a) increased inflammatory signaling,
           within the muscle and by peripheral blood mononuclear cells; (b) Decreased insulin
           signaling as characterized by decreased, whole body, peripheral insulin sensitivity
           (euglycemic/hyperinsulinemic clamp) and, in skeletal muscle, decreased phospho-AKT
           (Ser473), increased phospho-IRS-1 (Ser636/Ser639), decreased tyrosine phosphorylation of
           IRS-1, and decreased membrane content of GLUT4.

        2. To test the hypothesis that increased intake of PA will cause less complete
           mitochondrial fatty acid oxidation, perhaps associated with dysfunction of the TCA cycle
           and increased reactive oxygen species formation. This hypothesis will be tested by
           measuring whole body and muscle (upper limb) relative rates of oxidation of [13-13C]-PA
           and [1-13C]-PA and by determining the serum profile of acylcarnitines, the urine
           concentrations of organic acids, and muscle concentrations of protein carbonyls.

        3. To test the hypothesis that a high PA diet will lead to less complete oxidation of FA,
           less insulin signaling in skeletal muscle in response to a test meal, less whole body
           insulin sensitivity, increased dysfunction of the TCA cycle, and greater reactive oxygen
           species formation compared to the results obtained in obese versus lean humans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whether increased palmitate balance (as measured by intake and the rate of [1-13C]-PA oxidation) causes increased insulin resistance and increased inflammatory signaling by peripheral blood mononuclear cells</measure>
    <time_frame>up to 4 yr</time_frame>
    <description>Insulin sensitivity, inflammatory signaling, palmitate balance, and incomplete oxidation of palmitate in lean and obese young adults.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>We will examine the link between palmitate intake and balance and oxidative stress measured using muscle and peripheral blood markers of oxidative stress and antioxidant responses.</measure>
    <time_frame>up to 4 yr</time_frame>
    <description>activation of c-Jun N-terminal kinase (JNK) and heme oxygenase 1 in skeletal muscle in response to the diets.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>High palmitate or high oleate diet.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a solid food diet in which vegetable oils are used to create a dietary fat composition similar to the average American/Western diet in which palmitic and oleic acid are ingested in approximately equal amounts (high palmitate diet) or a composition similar to the Mediterranean Diet (low palmitate, high oleate, using hazelnut oil as the source of fat). There are no interventions other than the diet itself.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high palmitate or high oleate diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a solid food diet in which vegetable oils are used to create a dietary fat composition similar to the average American/Western diet in which palmitic and oleic acid are ingested in approximately equal amounts (high palmitate diet) or a composition similar to the Mediterranean Diet (low palmitate, high oleate, using hazelnut oil as the source of fat). There are no interventions other than the diet itself.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High palmitate or high oleate diet.</intervention_name>
    <description>High palmitate diet composition: Fat, 40.4% kcal; palmitic acid, 16.0% kcal; oleic acid,16.2% kcal. High oleate diet composition: Fat, 40.1% kcal; palmitic acid, 2.4% kcal; oleic acid, 28.8% kcal</description>
    <arm_group_label>High palmitate or high oleate diet.</arm_group_label>
    <arm_group_label>high palmitate or high oleate diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy young adults,

          -  18 - 40 years of age

        Exclusion Criteria:

          -  regular aerobic exercise training,

          -  dyslipidemia, and

          -  type 2 diabetes or insulin resistance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig L. Kien, M.D, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Vermont</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Unversity of Vermont Clinical Research Center at Fletcher Allen Health Care</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.uvm.edu/medicine/medicine/endocrinology/?Page=research_lab-kien.html&amp;SM=researchsubmenu.html</url>
    <description>Description of Kien Lab at the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Vermont College of Medicine</description>
  </link>
  <reference>
    <citation>Kien CL, Everingham KI, D Stevens R, Fukagawa NK, Muoio DM. Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity (Silver Spring). 2011 Feb;19(2):305-11. doi: 10.1038/oby.2010.135. Epub 2010 Jun 17.</citation>
    <PMID>20559306</PMID>
  </reference>
  <reference>
    <citation>Kien CL, Bunn JY, Stevens R, Bain J, Ikayeva O, Crain K, Koves TR, Muoio DM. Dietary intake of palmitate and oleate has broad impact on systemic and tissue lipid profiles in humans. Am J Clin Nutr. 2014 Mar;99(3):436-45. doi: 10.3945/ajcn.113.070557. Epub 2014 Jan 15.</citation>
    <PMID>24429541</PMID>
  </reference>
  <results_reference>
    <citation>Kien CL, Bunn JY, Tompkins CL, Dumas JA, Crain KI, Ebenstein DB, Koves TR, Muoio DM. Substituting dietary monounsaturated fat for saturated fat is associated with increased daily physical activity and resting energy expenditure and with changes in mood. Am J Clin Nutr. 2013 Apr;97(4):689-97. doi: 10.3945/ajcn.112.051730. Epub 2013 Feb 27. Erratum in: Am J Clin Nutr. 2013 Aug;98(2):511.</citation>
    <PMID>23446891</PMID>
  </results_reference>
  <results_reference>
    <citation>Kien CL, Bunn JY, Poynter ME, Stevens R, Bain J, Ikayeva O, Fukagawa NK, Champagne CM, Crain KI, Koves TR, Muoio DM. A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes. 2013 Apr;62(4):1054-63. doi: 10.2337/db12-0363. Epub 2012 Dec 13.</citation>
    <PMID>23238293</PMID>
  </results_reference>
  <results_reference>
    <citation>Kien CL, Matthews DE, Poynter ME, Bunn JY, Fukagawa NK, Crain KI, Ebenstein DB, Tarleton EK, Stevens RD, Koves TR, Muoio DM. Increased palmitate intake: higher acylcarnitine concentrations without impaired progression of Î²-oxidation. J Lipid Res. 2015 Sep;56(9):1795-807. doi: 10.1194/jlr.M060137. Epub 2015 Jul 8.</citation>
    <PMID>26156077</PMID>
  </results_reference>
  <results_reference>
    <citation>Kien CL, Bunn JY, Fukagawa NK, Anathy V, Matthews DE, Crain KI, Ebenstein DB, Tarleton EK, Pratley RE, Poynter ME. Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes. J Nutr Biochem. 2015 Dec;26(12):1599-606. doi: 10.1016/j.jnutbio.2015.07.014. Epub 2015 Aug 1.</citation>
    <PMID>26324406</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2012</study_first_submitted>
  <study_first_submitted_qc>June 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2012</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Craig Lawrence Kien</investigator_full_name>
    <investigator_title>The Mary Kay Davignon Green and Gold Professor, Depts. of Pediatrics and Medicine</investigator_title>
  </responsible_party>
  <keyword>humans</keyword>
  <keyword>lean</keyword>
  <keyword>obese</keyword>
  <keyword>saturated fat</keyword>
  <keyword>monounsaturated fat</keyword>
  <keyword>insulin sensitivity</keyword>
  <keyword>inflammation</keyword>
  <keyword>oxidant stress</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

